Trigeminal Neuralgia Surgery (Microvascular Decompression)

Introduction

Trigeminal neuralgia is a condition that causes sudden, severe, electric-shock-like pain in the face. The pain follows the path of the trigeminal nerve, which carries sensation from the face to the brain. For many people, the pain begins as occasional attacks but becomes more frequent and harder to control over time. Medicines often help at first, but for some patients they stop working, cause unacceptable side effects, or never bring full relief.

When that happens, surgery becomes one of the options to consider. Microvascular decompression, often shortened to MVD, is the surgical treatment that addresses what is believed to be the most common underlying cause of trigeminal neuralgia: a small blood vessel pressing on the trigeminal nerve where it leaves the brainstem. By moving that vessel away from the nerve and placing a soft cushion between them, the surgery aims to stop the irritation that triggers the pain.

This article is written for patients (and family members) who have been diagnosed with trigeminal neuralgia and are now considering or planning surgery. It explains what MVD is, who tends to be a good candidate, what other surgical and non-surgical options exist, what happens before, during, and after the operation, and what life typically looks like in the months and years that follow. The aim is to help you have a more informed conversation with your neurosurgeon and neurologist about the path that fits your situation.

What Is Microvascular Decompression?

Microvascular decompression is a neurosurgical operation performed inside the skull, behind the ear, to relieve pressure on the trigeminal nerve. The trigeminal nerve is the fifth cranial nerve and the largest of the cranial nerves. It has three branches that supply sensation to the forehead and eye area (V1), the cheek and upper jaw (V2), and the lower jaw (V3). In trigeminal neuralgia, even light touch — brushing teeth, a breeze on the face, chewing — can set off a brief but intense burst of pain along one or more of these branches.

In most patients with classical trigeminal neuralgia, high-resolution MRI scans show a blood vessel — usually a small artery, sometimes a vein — touching or compressing the trigeminal nerve very close to the brainstem. Over years, this pulsating contact is thought to wear down the protective myelin sheath of the nerve, leaving the nerve fibres misfiring and producing the characteristic pain attacks.

MVD is the only commonly performed treatment for trigeminal neuralgia that addresses this presumed cause directly rather than damaging the nerve to interrupt pain signals. The neurosurgeon makes a small opening in the skull behind the ear, locates the trigeminal nerve, identifies the blood vessel pressing on it, gently lifts the vessel away, and places a small piece of soft material (usually Teflon felt) between the vessel and the nerve. The nerve itself is left intact. Because the nerve is preserved, most patients who have a successful MVD do not develop the facial numbness that can follow other surgical treatments.

MVD is classified as an open posterior fossa craniotomy. Despite the technical sound of that description, it is a well-established operation performed routinely at experienced neurosurgical centres, and it is widely regarded by major neurology and neurosurgery societies as offering the best long-term pain relief among surgical options for classical trigeminal neuralgia.

Why Is Microvascular Decompression Performed?

MVD is performed to treat trigeminal neuralgia in people for whom medicines no longer provide enough relief, cause troubling side effects, or are not a workable long-term option. Trigeminal neuralgia comes in different forms, and the type of pain influences how well surgery is likely to work.

Classical Trigeminal Neuralgia

Classical trigeminal neuralgia is the form caused by a blood vessel compressing the nerve. It typically produces sharp, sudden, shock-like pain attacks that last seconds to a couple of minutes, often triggered by light touch, talking, eating, or cold air. Between attacks, the face usually feels normal. This is the form of trigeminal neuralgia for which MVD has the strongest evidence of benefit.

Secondary Trigeminal Neuralgia

Secondary trigeminal neuralgia is caused by an identifiable condition such as multiple sclerosis, a tumour pressing on the nerve, or an arteriovenous malformation. In multiple sclerosis, the pain comes from demyelination of the nerve itself, not from a blood vessel pressing on it, so MVD usually does not help as well. In tumour-related cases, surgery is directed at removing the tumour. Your neurosurgeon will look carefully at your MRI before recommending an approach.

Idiopathic Trigeminal Neuralgia

When the MRI does not clearly show a compressing vessel but the pain pattern is classical, the condition is called idiopathic. Some patients in this group still benefit from MVD because subtle compression may be present that imaging does not capture, but outcomes are generally less predictable than in clearly classical cases.

When Surgery Is Considered

Most professional guidelines, including those from the American Academy of Neurology and the European Academy of Neurology, recommend that medication be tried first. Carbamazepine and oxcarbazepine are usually the first-line drugs. When two adequately trialled medicines fail to control pain, or when side effects become intolerable, surgical options are typically discussed. There is also a growing view that earlier referral for surgery, before years of escalating medication, may give better long-term outcomes for suitable patients — this is something to raise with your neurologist.

Who Is a Candidate for MVD?

Not everyone with trigeminal neuralgia is a candidate for MVD. The factors a neurosurgical team usually considers include:

• Type of pain. Classical, episodic, shock-like pain in a trigeminal distribution responds best. Constant burning or aching pain (sometimes called atypical or type 2 trigeminal neuralgia) tends to respond less well to MVD.
• MRI findings. A high-resolution MRI showing vascular contact with the trigeminal nerve supports the case for MVD.
• Response to carbamazepine or oxcarbazepine. A history of good initial response to these medicines is a positive predictor of MVD success, because it suggests the pain is genuinely classical trigeminal neuralgia rather than another facial pain syndrome.
• Age and general health. MVD is a craniotomy under general anaesthesia. Patients need to be fit enough for that. Age alone is not an automatic disqualifier — healthy older adults do undergo MVD — but overall cardiopulmonary fitness, other medical conditions, and bleeding risk all come into the assessment.
• Patient preference. Some patients prefer a less invasive procedure even if the long-term pain relief is lower; others prioritise the best chance of long-term, drug-free pain relief and accept the larger operation. There is no single right answer, and the conversation with your surgeon matters.

Patients with secondary trigeminal neuralgia from multiple sclerosis, severe medical comorbidities, or anatomy that makes the operation high-risk are usually directed towards one of the alternative procedures described below.

Alternatives to MVD

For trigeminal neuralgia that no longer responds adequately to medication, several alternatives to MVD exist. Each has a different balance of pain relief, durability, and side effects, and the best fit varies from person to person.

Continued Medical Therapy

Before any surgical option is offered, doctors usually optimise medical treatment. Carbamazepine and oxcarbazepine are the mainstay first-line drugs. Other options include lamotrigine, baclofen, gabapentin, and pregabalin, sometimes used in combination. Side effects such as drowsiness, dizziness, low sodium, rash, and cognitive slowing are common and limit how high doses can be pushed. For some patients, medication remains the right long-term path.

Percutaneous Procedures (Rhizotomy)

• Radiofrequency thermocoagulation — a heated needle tip damages selected nerve fibres.
• Glycerol injection — a small amount of glycerol is injected to chemically damage the nerve fibres.
• Balloon compression — a small balloon is inflated briefly to compress the nerve.

Percutaneous procedures are shorter, do not require opening the skull, and can be performed under sedation or short general anaesthesia. Initial pain relief is high. The trade-off is that pain often returns within a few years, requiring repeat treatment, and most patients are left with some degree of facial numbness on the treated side. Corneal sensation can be reduced, raising a small risk of eye complications.

These procedures are often preferred for older patients, patients with significant medical risks for craniotomy, patients with multiple sclerosis, and patients who want a less invasive approach even at the cost of likely repeat treatment.

Stereotactic Radiosurgery

Stereotactic radiosurgery, often delivered using a Gamma Knife or Cyberknife system, focuses high-dose radiation on a small target in the trigeminal nerve root. The radiation gradually damages the nerve over weeks, with the aim of reducing pain signal transmission. It is non-invasive, usually done in a single outpatient session, and requires no general anaesthesia.

Pain relief is typically not immediate — it can take weeks to months to develop. Long-term pain control is reasonable but generally less durable than MVD, and facial numbness can develop over time. Radiosurgery is often considered for older patients, those who cannot tolerate open surgery, or those who prefer to avoid a needle procedure.

How Doctors Compare the Options

In broad terms, current professional guidance describes MVD as offering the highest rate of long-term, drug-free pain relief among the surgical options for classical trigeminal neuralgia, but at the cost of a larger operation. Percutaneous procedures and stereotactic radiosurgery offer shorter recovery and lower procedural risk but tend to have shorter durability and a higher likelihood of facial numbness. Major societies recommend that all options be discussed with patients, and that the choice be tailored to the patient's age, health, MRI findings, pain pattern, and personal priorities.

Preparing for MVD

Once you and your neurosurgeon have decided on MVD, preparation typically unfolds over the days to weeks before surgery.

Imaging and Tests

You will usually have a high-resolution MRI of the brain, including specific sequences designed to visualise the trigeminal nerve and the small blood vessels around it. If you have not had one recently, this will be arranged. Standard pre-operative tests — blood work, ECG, chest imaging, and others depending on your health — are done to check fitness for anaesthesia.

Medication Review

Your team will review all your medicines. Blood thinners such as aspirin, clopidogrel, warfarin, and direct oral anticoagulants are usually stopped or adjusted before surgery, with timing depending on the specific drug. Some other medications may also need to be paused. Do not stop any medicine on your own — your team will give you specific instructions.

You will usually continue your trigeminal neuralgia medication right up to the day of surgery and for some time afterwards. Reducing or stopping it is done gradually after pain relief is confirmed.

Lifestyle and Practical Preparation

Stopping smoking before surgery, even for a few weeks, reduces complications. Keeping general health, blood pressure, and diabetes well controlled also helps. Practical preparation includes arranging time off work (often four to six weeks), help at home for the first one to two weeks, and a plan for getting to and from hospital. A small patch of hair behind the ear on the operated side is usually shaved before or during surgery — most surgeons keep this area small.

Informed Consent

Your surgeon will go through the risks and benefits with you in detail and ask you to sign a consent form. This is a good moment to ask any remaining questions, including how many MVD operations the team performs per year, what their experience is with your specific situation, and what to expect in the days after surgery.

What Happens During MVD

The operation usually takes between two and four hours, though this can vary depending on anatomy and findings.

Anaesthesia and Positioning

MVD is performed under general anaesthesia. Once you are asleep, you are positioned with your head turned and held in a fixation device that keeps it perfectly still. The skin behind the ear on the affected side is cleaned and prepared.

The Craniotomy

The surgeon makes an incision behind the ear and creates a small opening in the bone of the skull, about the size of a large coin, in an area called the retrosigmoid region. The lining of the brain (the dura) is then opened.

Finding the Nerve and Vessel

Using an operating microscope or endoscope, the surgeon gently moves aside the edge of the cerebellum to expose the trigeminal nerve where it leaves the brainstem. The nerve is carefully inspected along its length. In most cases, one or more blood vessels are found in contact with the nerve.

Decompression

The offending vessel is gently lifted away from the nerve. A small piece of soft, inert material — most commonly Teflon felt — is placed between the vessel and the nerve so that the vessel cannot fall back against it. If multiple vessels are involved, each is addressed. If no clear vascular compression is found, some surgeons will still gently manipulate the nerve (a procedure sometimes called internal neurolysis), although this is a judgement call discussed beforehand.

Closure

The dura is closed in a watertight fashion. The bone is replaced or, in some techniques, a small bone substitute is used. The muscle and skin layers are closed. A dressing is placed behind the ear. You are woken from anaesthesia and moved to a recovery area.

Many neurosurgeons use intraoperative neurophysiological monitoring during MVD, which tracks the function of nearby cranial nerves (especially the hearing nerve) in real time. This is intended to reduce the risk of hearing loss and other cranial nerve injuries.

Recovery and Healing

The First Few Days in Hospital

You will usually wake in a recovery area or intensive care unit for close monitoring overnight, then transfer to a regular ward. Headache is common in the first days — both from the operation itself and from changes in the cerebrospinal fluid pressure — and is managed with pain medication. Nausea is also common in the first day or two. Many patients notice that their trigeminal neuralgia pain is already gone or much reduced when they wake up, although this can also take days to weeks to settle.

The hospital stay is typically three to five days, depending on recovery and local practice. You will be encouraged to get up and walk as early as comfortable. The wound behind the ear is checked and the dressing changed before discharge.

The First Few Weeks at Home

At home, the main focus is on rest, gradual return to light activity, and avoiding anything that strains the head or neck. Typical guidance includes:

• Resting as needed and getting enough sleep
• Short, gentle walks, increased gradually
• Avoiding heavy lifting (generally anything more than 4–5 kg) for several weeks
• Avoiding strenuous exercise, contact sport, and swimming until cleared
• Keeping the wound clean and dry as instructed
• Watching for signs of infection, cerebrospinal fluid leak, or wound problems and contacting the team if they appear

Many patients feel tired and need more sleep than usual for several weeks. Mild headache, neck stiffness, and a feeling of fullness or sensitivity around the wound are common and usually settle over a few weeks. Some patients notice mild balance changes initially, which typically improve.

Returning to Work and Normal Life

Most patients are able to return to office-type work in four to six weeks. Physically demanding work may take longer. Driving is usually restricted until your surgeon confirms it is safe. Air travel is often deferred for a few weeks. Each centre has its own guidance, and these timelines should be discussed with your team.

Coming Off Medication

If your trigeminal neuralgia pain is well controlled after MVD, your neurologist will usually taper your medication gradually rather than stopping it suddenly. Sudden withdrawal of carbamazepine or related drugs can cause side effects, so the reduction is typically done over weeks. Some patients are able to come off medication completely; others stay on a lower dose.

Risks and Complications

MVD is a brain operation, and although it is performed routinely with good safety at experienced centres, it carries real risks that should be understood before consenting.

Risks Specific to MVD

• Hearing loss. The hearing nerve runs close to the surgical area. Some degree of hearing reduction on the operated side can occur, ranging from mild and temporary to, rarely, more significant. Intraoperative monitoring is used to reduce this risk.
• Facial numbness or weakness. Because the nerve itself is not deliberately damaged, persistent facial numbness is less common than after percutaneous procedures, but it can occur, especially if the nerve is bruised during surgery. Facial weakness is rare.
• Cerebrospinal fluid (CSF) leak. Fluid that surrounds the brain can leak through the wound or out of the nose, sometimes requiring further treatment.
• Infection. Wound infection or, rarely, meningitis can occur and is treated with antibiotics and, if needed, further procedures.
• Double vision or other cranial nerve effects. Temporary effects on nerves controlling eye movement, swallowing, or facial sensation are uncommon but possible.
• Cerebellar injury. Bruising or, rarely, a small stroke in the cerebellum can affect balance and coordination.
• Bleeding and stroke. Bleeding inside the skull is uncommon but possible and can have serious consequences.
• Persistent or recurrent pain. Some patients do not get full pain relief, and others have pain return after months or years.

General Risks of Surgery and Anaesthesia

As with any major operation under general anaesthesia, there are general risks including reactions to anaesthesia, blood clots in the legs or lungs, chest infection, and very rarely, death. In contemporary surgical series at experienced centres, the risk of death from MVD is low — consistently reported as well under one percent. Your specific risk depends on your age, overall health, and the centre's experience, and is best discussed individually with your surgeon.

How Risk Is Reduced

Risks are lower when MVD is performed by surgeons and teams who do the operation regularly. Other factors that reduce risk include careful pre-operative imaging, use of an operating microscope or endoscope, intraoperative neurophysiological monitoring, and good post-operative care. Asking about the team's MVD experience is reasonable and expected.

Life After MVD

For most patients with classical trigeminal neuralgia who undergo MVD at an experienced centre, the operation produces substantial, lasting pain relief. Large surgical series consistently report that the majority of patients are pain-free or nearly pain-free in the immediate post-operative period, and that a large proportion remain so years later. Pain relief is generally more durable than with percutaneous procedures or radiosurgery, and most patients do not develop facial numbness.

Immediate Pain Relief

Many patients wake up from surgery without their familiar pain. For others, relief develops over days to weeks as the nerve recovers. Some pain in the first weeks can come from the surgery itself rather than from trigeminal neuralgia — your team will help distinguish the two.

Long-term Outcomes

Over years, a smaller percentage of patients experience some return of pain. When this happens, options include restarting medication, considering a repeat MVD if a new or missed vascular contact is suspected, or one of the other procedures. Long-term follow-up with a neurologist familiar with trigeminal neuralgia is helpful.

Emotional Adjustment

Living with severe facial pain for months or years takes a real psychological toll. After successful surgery, many patients describe relief that goes beyond the absence of pain — sleep improves, eating and talking become normal again, and confidence returns. For some patients, the adjustment is gradual, and anxiety about whether the pain will come back can linger. Counselling, peer support groups, and continued conversation with your team can help.

Follow-up

You will usually be seen by your neurosurgeon a few weeks after surgery to check the wound and overall recovery, and then at longer intervals. Your neurologist remains involved in tapering medication and following up the pain itself. A follow-up MRI is not routine in all centres but may be done in some cases.

Frequently Asked Questions

How soon after surgery will I know if MVD worked?

Many patients notice that their trigeminal neuralgia pain is gone or much better as soon as they wake up. In others, pain relief develops over days to weeks. If pain has not improved by a few weeks, your team will look into why — for example, whether more than one vessel was involved or whether the diagnosis needs to be revisited.

Will my face be numb after MVD?

One of the main reasons MVD is favoured for suitable patients is that, because the nerve itself is preserved, persistent facial numbness is uncommon. Some patients have mild, temporary changes in sensation that settle, but lasting numbness is much less common than after percutaneous procedures.

How long does the relief last?

For most patients, MVD provides durable relief. Major surgical series report that a large proportion of patients remain pain-free or have major improvement years after surgery, with relief generally more durable than after percutaneous procedures or radiosurgery. A smaller proportion of patients have pain return over time, and options exist if that happens.

Can MVD be repeated if the pain comes back?

Yes, repeat MVD is possible in selected patients, particularly if imaging suggests a new or previously missed vascular contact. Repeat surgery is technically more demanding and the decision depends on imaging, time since the first operation, and the pattern of returning pain. Other options — medication, percutaneous procedures, radiosurgery — are also considered.

Am I too old for MVD?

Age alone does not rule out MVD. Healthy older adults do undergo the operation. What matters more is overall fitness for general anaesthesia and the absence of medical conditions that significantly increase surgical risk. For patients in whom craniotomy is judged too risky, percutaneous procedures and stereotactic radiosurgery are commonly considered.

What if my trigeminal neuralgia is caused by multiple sclerosis?

When trigeminal neuralgia is caused by demyelination from multiple sclerosis rather than vascular compression, MVD is generally less effective. Doctors more commonly recommend medical optimisation, percutaneous procedures, or stereotactic radiosurgery in this situation. The right approach depends on individual MRI findings and a discussion with both a neurologist and a neurosurgeon.

Does MVD treat all facial pain, or only certain types?

MVD specifically targets classical trigeminal neuralgia. Other facial pain syndromes — such as persistent idiopathic facial pain, atypical odontalgia, cluster headache, or temporomandibular joint disorders — have different causes and different treatments. Making the correct diagnosis before considering surgery is essential, which is why a careful evaluation by a neurologist is usually part of the path to MVD.

Can children get trigeminal neuralgia?

Trigeminal neuralgia in children is rare. When it occurs, secondary causes such as multiple sclerosis or a tumour are more often considered. Evaluation in a paediatric neurology setting, with appropriate imaging, is essential before considering surgery.

How long will I be in hospital?

Most patients stay in hospital for around three to five days after MVD, though this can vary by centre and individual recovery.

Can I fly home soon after surgery?

Air travel soon after a craniotomy is usually not recommended. Most teams ask patients to wait several weeks before flying, and the exact timing should be discussed with your surgeon based on your recovery.

Conclusion

Microvascular decompression is the surgical option that comes closest to treating the underlying cause of classical trigeminal neuralgia rather than only blocking the pain signal. For patients whose pain is no longer controlled by medication and whose imaging and pain pattern fit, it offers the best long-term chance of being pain-free without facial numbness — but at the cost of an operation that opens the skull and carries real, if generally low, risks.

The decision between MVD, percutaneous procedures, stereotactic radiosurgery, and continued medication is rarely a single right answer. It depends on the type of pain, the MRI findings, your age and overall health, how much you value durable, drug-free relief against shorter recovery and lower procedural risk, and the experience of the team available to you. Major neurology and neurosurgery societies recommend that all these options be discussed openly, and that the choice be made together with a neurosurgeon and neurologist who know your case in detail. With the right diagnosis, the right procedure, and an experienced team, most patients who have lived with the disabling pain of trigeminal neuralgia can expect meaningful improvement and a return to ordinary daily life.